人工智能的快速迭代正在带动“数智医疗”的发展,数智技术在智能辅助诊断、手术机器人、智能康复等场景创新应用,带动了医疗健康质量提高、医疗效率提升和医疗模式转变,推动医疗健康服务迈向更高阶的模式。日前,由中国医学装备协会健康管理装备与技术分会和上海健康医学院共同主办的“2023中国健康装备与技术大会暨第三届中国健康管理国际论坛”在上海健康医学院拉开帷幕。大会聚焦新医科、新工科交叉学科建设、装备与技术创新、临床转化应用等,邀请国内外知名专家学者探讨行业发展趋势,提升健康管理事业在全国医疗健康服务领域的学术影响力,推动健康事业高质量发展。
健康管理和相关装备技术的发展正处于重要的战略机遇期,新一代人工智能技术的发展,为医疗健康产业转型和升级带来了新的契机,数智化技术改变着健康领域的发展模式。中国医学装备协会理事长侯岩表示,应充分重视全生命周期的健康管理,满足人民群众从出生到老龄的健康需求,积极构建多元化的服务体系,提供更加全面和便捷的健康服务,打造更多创新化、智能化产品,适应目前主动健康、家庭健康的发展需要。此外,还需要关注政策支持与行业监管,为医疗健康事业的发展提供更加稳定、可靠的支持和保障。
The rapid iteration of artificial intelligence is driving the development of "digital healthcare". Digital technology has been innovatively applied in scenarios such as intelligent assisted diagnosis, surgical robots, and intelligent rehabilitation, driving the improvement of medical health quality, efficiency, and transformation of medical models, and advancing medical and health services to higher levels. Recently, the "2023 China Health Equipment and Technology Conference and the Third China Health Management International Forum" jointly hosted by the Health Management Equipment and Technology Branch of the China Medical Equipment Association and Shanghai Health Medical College opened at Shanghai Health Medical College. The conference focuses on the interdisciplinary construction of new medical and engineering disciplines, equipment and technology innovation, clinical transformation and application, and invites well-known domestic and foreign experts and scholars to discuss industry development trends, enhance the academic influence of health management in the national medical and health service field, and promote high-quality development of the health industry.
As of the end of 2022, the number of medical device manufacturing enterprises in China exceeded 30000, among which industrial enterprises above designated size had a main business income of 757.7 billion yuan, forming a group of collaborative and distinctive industrial clusters. However, there are still problems such as low R&D investment, weak innovation ability, high technical barriers in the high-end market, and low industry concentration. Yu Qingming, Secretary of the Party Committee and Chairman of China National Pharmaceutical Holdings Co., Ltd., mentioned in a speech titled "The Digital Development Path of China's Medical Device Industry" that China has become the world's second largest medical device market after the United States. He believes that the current development trend of China's medical device industry is first driven by innovation, followed by Chinese manufacturing, scale customization, digital transformation, and ecological competition. He called for strengthening clinical demand and medical industry cooperation in the future, assisting in medical transformation, and accelerating the industrialization of scientific research achievements; Aggregating the advantages of multiple resources from industry, academia, and research, building a new transformation platform, exploring new transformation mechanisms, breaking through key common technical barriers, empowering clinical transformation needs through multiple links, and "building bridges and roads" are the key links to accelerate the transformation and listing of clinical innovation achievements.
The development of health management and related equipment technology is currently in an important strategic opportunity period. The development of the new generation of artificial intelligence technology has brought new opportunities for the transformation and upgrading of the medical and health industry, and digital technology is changing the development mode of the health field. Hou Yan, Chairman of the China Medical Equipment Association, stated that full attention should be paid to health management throughout the entire life cycle, to meet the health needs of the people from birth to aging, actively build a diversified service system, provide more comprehensive and convenient health services, create more innovative and intelligent products, and adapt to the current development needs of active health and family health. In addition, it is necessary to pay attention to policy support and industry regulation, in order to provide more stable and reliable support and guarantee for the development of the medical and health industry.